PRIME EYECARE XL LIMITED

(Company Number 13174309)

Registered office: c/o Bridgewood Financial Solutions Limited, Cumberland House, 35 Park Row, Nottingham, NG1 6EE c/o 7 Greenhill Avenue, Winchester, SO22 5ED

Principal trading address: 7 Greenhill Avenue, Winchester, SO22 5ED

NOTICE IS GIVEN pursuant to Rule 14.28 of the Insolvency (England & Wales) Rules 2016, that the Joint Liquidators of the above named Company, which was wound up voluntarily on 12 May 2025, intend to make a first and final dividend to creditors.

Creditors of the Company are required, on or before 14 June 2025, to prove their debts by delivering their proofs (in the format specified in Rule 14.4 of the Insolvency (England & Wales) Rules 2016, to the Joint Liquidators at Bridgewood Financial Solutions Ltd, Cumberland House, 35 Park Row, Nottingham, NG1 6EE. If so required by notice from the Joint Liquidators, creditors must produce any document or other evidence which the Joint Liquidators consider is necessary, to substantiate the whole or any part of a claim.

The Directors of the Company have made a declaration of solvency and It is expected that all creditors will be paid in full

The distribution maybe made without regard to the claim of any person in respect of a debt not proved.

Joint Liquidator: Andrew Smith (IP number 19210) of Bridgewood Financial Solutions Limited, Cumberland House, 35 Park Row, Nottingham, NG1 6EE.

Joint Liquidator: Thomas Grummitt (IP number 25976) of Bridgewood Financial Solutions Limited, Cumberland House, 35 Park Row, Nottingham, NG1 6EE.

For further details contact Elizabeth Richards on 115 871 2940 or at elizabeth.richards@bridgewood.co.uk